C-peptide level as predictor of type 2 diabetes remission and body composition changes in non-diabetic and diabetic patients after Roux-en-Y gastric bypass

Imagem de Miniatura
Arquivos
art_CLEVA_Cpeptide_level_as_predictor_of_type_2_diabetes_2021.PDF (175.35 KB)
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2021
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Autores
BORGES, Georgia
Citação
CLINICS, v.76, article ID e2906, 5p, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVES: Several predictors of type 2 diabetes mellitus (T2DM) remission after metabolic surgery have been proposed and used to develop predictive scores. These scores may not be reproducible in diverse geographic regions with different baseline characteristics. This study aimed to identify predictive factors associated with T2DM remission after Roux-en-Y gastric bypass (RYGB) in patients with severe obesity. We hypothesized that the body composition alterations induced by bariatric surgery could also contribute to diabetes remission. METHODS: We retrospectively evaluated 100 patients with severe obesity and T2DM who underwent RYGB between 2014 and 2016 for preoperative factors (age, diabetes duration, insulin use, HbA1c, C-peptide plasma level, and basal insulinemia) to identify predictors of T2DM remission (glycemia<126 mg/dL and/or HbA1c<6.5%) at 3 years postoperatively. The potential preoperative predictors were prospectively applied to 20 other patients with obesity and T2DM who underwent RYGB for validation. In addition, 81 patients with severe obesity (33 with T2DM) underwent body composition evaluations by bioelectrical impedance analysis (InBody 770 (R)) 1 year after RYGB for comparison of body composition changes between patients with and those without T2DM. RESULTS: The retrospective analysis identified only a C-peptide level >3 ng/dL as a positive predictor of 3-year postoperative diabetes remission, which was validated in the prospective phase. There was a significant difference in the postoperative body composition changes between non-diabetic and diabetic patients only in trunk mass. CONCLUSION: Preoperative C-peptide levels can be useful for predicting T2DM remission after RYGB. Trunk mass is the most important difference in postoperative body composition changes between non-diabetic and diabetic patients.
Palavras-chave
Type 2 Diabetes Mellitus, Bariatric Surgery, Diabetes Remission, C-peptide
URI
https://observatorio.fm.usp.br/handle/OPI/42211
Referências
  1. Aarts EO, 2013, OBES SURG, V23, P867, DOI 10.1007/s11695-013-0872-8
  2. Ahuja A, 2018, OBES SURG, V28, P2025, DOI 10.1007/s11695-018-3136-9
  3. Aminian A, 2017, ANN SURG, V266, P650, DOI 10.1097/SLA.0000000000002407
  4. Aron-Wisnewsky J, 2017, DIABETOLOGIA, V60, P1892, DOI 10.1007/s00125-017-4371-7
  5. Batterham RL, 2016, DIABETES CARE, V39, P893, DOI 10.2337/dc16-0145
  6. Belligoli A, 2020, CURR OBES REP, V9, P373, DOI 10.1007/s13679-020-00390-1
  7. Bhasker AG, 2015, OBES SURG, V25, P1191, DOI 10.1007/s11695-014-1501-x
  8. Blackstone R, 2012, SURG OBES RELAT DIS, V8, P548, DOI 10.1016/j.soard.2012.05.005
  9. Dantas WS, 2020, DIABETES, V69, P1675, DOI 10.2337/db19-1180
  10. De Luca M, 2016, OBES SURG, V26, pS422, DOI 10.1007/s11695-016-2271-4
  11. Diaz-Cerezo S, 2020, CURR MED RES OPIN, V36, P1449, DOI [10.1080/03007995.2020.1793749, DOI 10.1080/03007995.2020.1793749]
  12. Dirksen C, 2012, DIABETOLOGIA, V55, P1890, DOI 10.1007/s00125-012-2556-7
  13. Dixon JB, 2013, DIABETES CARE, V36, P20, DOI 10.2337/dc12-0779
  14. Fernandes G, 2019, SURG OBES RELAT DIS, V15, P595, DOI 10.1016/j.soard.2019.01.013
  15. Jeon JY, 2014, DIABETES METAB J, V38, P197, DOI 10.4093/dmj.2014.38.3.197
  16. Lee WJ, 2015, J BIOMED RES, V29, P98, DOI 10.7555/JBR.28.20140120
  17. Lee WJ, 2013, SURG OBES RELAT DIS, V9, P379, DOI 10.1016/j.soard.2012.07.015
  18. Maegawa H, 2021, J DIABETES INVEST, V12, P374, DOI 10.1111/jdi.13352
  19. Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024
  20. Pajecki Denis, 2013, Rev. Col. Bras. Cir., V40, P191
  21. Panunzi S, 2016, DIABETES CARE, V39, P166, DOI 10.2337/dc15-0575
  22. Park JY, 2018, J OBES METAB SYNDR, V27, P213, DOI 10.7570/jomes.2018.27.4.213
  23. Park JY, 2016, OBES SURG, V26, P749, DOI 10.1007/s11695-015-1823-3
  24. Purnell JQ, 2016, DIABETES CARE, V39, P1101, DOI 10.2337/dc15-2138
  25. Rubino F, 2016, DIABETES CARE, V39, P861, DOI 10.2337/dc16-0236
  26. Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225
  27. Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012
  28. Still CD, 2019, SURG OBES RELAT DIS, V15, P717, DOI 10.1016/j.soard.2018.12.020
  29. Still CD, 2014, LANCET DIABETES ENDO, V2, P38, DOI 10.1016/S2213-8587(13)70070-6
  30. Takesian M, 2018, ABCD-ARQ BRAS CIR DI, V31, DOI 10.1590/0102-672020180001e1362
  31. Tharakan G, 2017, OBES SURG, V27, P782, DOI 10.1007/s11695-016-2368-9
  32. Yan WM, 2017, J INVEST SURG, V30, P383, DOI 10.1080/08941939.2016.1259375

Coleções
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - LIM/35
Artigos e Materiais de Revistas Científicas - ODS/03